fenofibric acid 135 MG Delayed Release Oral Capsule [Trilipix]

RxNorm concept 828377, branded drug (sbd). Prescribable name: Trilipix 135 MG Delayed Release Oral Capsule.

RxCUI: 828377
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/828377 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

fenofibrate 8703

Other names

Trilipix 135 MG Delayed Release Oral Capsule

Related concepts

fenofibric acid 135 MG (SCDC, consists of)
fenofibric acid 135 MG [Trilipix] (SBDC, consists of)
Delayed Release Oral Capsule (DF, has dose form)
Trilipix (BN, has ingredient)
fenofibric acid 135 MG Delayed Release Oral Capsule (SCD, tradename of)

Linked data

NDCs

00074316290

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 828377 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/828377 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 828377. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.